Cytokine storm and immunomodulatory therapy in COVID 19: Role of chloroquine and anti IL 6 monoclonal antibodies
Highlights Discussion of the role of immunomodulatory agents to reduce the cytokine storm in severe cases of COVID 19. Potential immunomodulatory agents currently used in the treatment of COVID 19 (chloroquine, hydroxychloroquine and tocilizumab) are discussed. Other immunomodulatory agents with good safety profiles may be considered for use in combination with antiviral drugs for the treatment of severe or critical cases of COVID 19.
International Journal of Antimicrobial Agents